Filing Details
- Accession Number:
- 0001576885-24-000029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-19 19:07:42
- Reporting Period:
- 2024-01-19
- Accepted Time:
- 2024-01-19 19:07:42
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576885 | Acumen Pharmaceuticals Inc. | ABOS | Biological Products, (No Disgnostic Substances) (2836) | 364108129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1865136 | Joseph Daniel Oconnell | C/O Acumen Pharmaceuticals, Inc. 427 Park Street Charlottesville VA 22902 | President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-19 | 15,200 | $3.47 | 502,485 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the Reporting Person in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 9, 2023.
- The price reported is a weighted average sales price. The shares were sold in multiple transactions at prices ranging from $3.3950 to $3.6500. Upon request, the Reporting Person will provide to the staff of the Securities and Exchange Commission, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Billionaire Hedge Funds
